Código QR (código de barras bidimensional)

Research Advances of Immunotherapy of Exosome PD-L1 
in Non-small Cell Lung Cancer

Cancer immunotherapy is increasingly popular in the field of cancer treatment, and related research is emerging. For patients with non-small cell lung cancer (NSCLC), in recent years, immune checkpoint inhibitors (ICIs) represented by programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD...

ver descrição completa

Na minha lista:
Principais autores: Na WANG, Xia SONG
Formato: Artigo
Idioma:Chinês
Publicado em: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-09-01
coleção:Chinese Journal of Lung Cancer
Assuntos:
exosome
pd-l1
lung neoplasms
immunotherapy
Acesso em linha:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.33
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados